Hot Performing Stocks To Watch For 2019

Yes, Exact Sciences (NASDAQ:EXAS) stock is underperforming the S&P 500 so far this year. And yes, many investors were underwhelmed by the company’s choice of Harry Connick Jr. and his wife, Jill, to be featured in a national campaign to raise public awareness about cancer screening.

But no, this article isn’t a “hit piece” on Exact Sciences. Sure, the headline warns about getting greedy with the stock. That’s good advice for investors for any stock. In my view, there’s a lot for investors to like about Exact Sciences stock. However, there’s a danger in liking the stock too much.

Image source: Getty Images.

Reasons to like Exact Sciences

The numbers don’t lie: Exact Sciences’ Cologuard DNA screening test for colorectal cancer is a huge success story. Sales for Cologuard soared 168% higher year over year in 2017. Test volume increased 134%.

Hot Performing Stocks To Watch For 2019: Edwards Lifesciences Corporation(EW)

Advisors’ Opinion:

  • [By Max Byerly]

    Sanford C. Bernstein started coverage on shares of Edwards Lifesciences (NYSE:EW) in a research note published on Wednesday, Marketbeat Ratings reports. The firm issued a market perform rating and a $165.00 price target on the medical research company’s stock.

  • [By Ethan Ryder]

    Aperio Group LLC raised its holdings in shares of Edwards Lifesciences (NYSE:EW) by 15.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 96,340 shares of the medical research company’s stock after acquiring an additional 13,223 shares during the quarter. Aperio Group LLC’s holdings in Edwards Lifesciences were worth $13,441,000 as of its most recent filing with the SEC.

  • [By Logan Wallace]

    Sanford C. Bernstein began coverage on shares of Edwards Lifesciences (NYSE:EW). Sanford C. Bernstein issued a market perform rating on the stock.

  • [By Shane Hupp]

    Commerzbank Aktiengesellschaft FI reduced its position in shares of Edwards Lifesciences Corp (NYSE:EW) by 17.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 21,345 shares of the medical research company’s stock after selling 4,543 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in Edwards Lifesciences were worth $3,107,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By ]

    Edwards Lifesciences (EW) : “They have the best devices. That stock is a buy.”

    Align Technology (ALGN) : “The stock is breaking down. Let’s wait a few days then pull the trigger.”

Hot Performing Stocks To Watch For 2019: Koss Corporation(KOSS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) rose 32 percent to $2.89 in pre-market trading after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) rose 17.7 percent to $3.03 in pre-market trading after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares rose 12.7 percent to $3.55 in pre-market trading after the company announced the FDA acceptance of NDA for DSUVIA.
    Williams-Sonoma, Inc. (NYSE: WSM) shares rose 11.7 percent to $54.95 in pre-market trading. after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    Bilibili Inc. (NASDAQ: BILI) shares rose 9.3 percent to $13.59 in pre-market trading after announcing Q1 results.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 8.1 percent to $3.46 in pre-market trading after reporting strong Q1 earnings.
    Universal Corporation (NYSE: UVV) rose 8.1 percent to $52.35 in pre-market trading after reporting fiscal Q4 results.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 8.1 percent to $5.65 in pre-market trading after gaining 6.30 percent on Wednesday.
    CEL-SCI Corporation (NYSE: CVM) rose 6.1 percent to $3.30 in pre-market trading after climbing 9.51 percent on Wednesday.
    TransEnterix, Inc. (NYSE: TRXC) rose 6 percent to $3.10 in pre-market trading after reporting a loan deal for $40 million in term loans with Hercules Capital.
    Stage Stores, Inc. (NYSE: SSI) rose 5.6 percent to $3.40 in pre-market trading following Q1 results.
    Koss Corporation (NASDAQ: KOSS) shares rose 5.2 percent to $2.42 in the pre-market trading session after falling 2.54 percent on Wednesday.

     

  • [By Money Morning Staff Reports]

    However, Seven Star’s gains are already on the books. After looking at last week’s top performing penny stocks, we’ll show you a penny stock on the verge of jumping over 70%…

    Penny Stock Current Share Price Last Week’s Gain
    Seven Stars Cloud Group Inc. (Nasdaq: SSC) $4.49 175.13%
    Alliance MMA Inc. (Nasdaq: AMMA) $0.37 121.05%
    India Globalization Capital Inc. (NYSE: IGC) $1.14 74.38%
    Obalon Therapeutics Inc. (Nasdaq: OBLN) $3.23 63.16%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.56 55.76%
    Atlanticus Holdings Corp. (Nasdaq: ATLC) $2.85 43.55%
    Research Frontiers Inc. (Nasdaq: REFR) $1.28 41.37%
    Koss Corp. (Nasdaq: KOSS) $4.08 41.28%
    GLG Life Tech Corp. (TSE: GLG) $0.88 33.90%
    Geron Corp. (Nasdaq: GERN) $4.76 32.40%

    While those gains are already in the book, you don’t have to miss out on the next penny stocks to soar.

  • [By Lisa Levin] Gainers
    Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'.
    CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss.
    Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session.
    Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading.
    Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
    Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday.
    Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday.
    Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday.
    Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.

     

Hot Performing Stocks To Watch For 2019: Bioanalytical Systems, Inc.(BASI)

Advisors’ Opinion:

  • [By Max Byerly]

    Headlines about Bioanalytical Systems (NASDAQ:BASI) have been trending positive this week, according to Accern. The research firm scores the sentiment of media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bioanalytical Systems earned a news sentiment score of 0.27 on Accern’s scale. Accern also gave media headlines about the company an impact score of 47.5882570492565 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Hot Performing Stocks To Watch For 2019: Nuveen Preferred Income Opportunites Fund(JPC)

Advisors’ Opinion:

  • [By Max Byerly]

    Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) announced a monthly dividend on Wednesday, August 1st, NASDAQ reports. Shareholders of record on Wednesday, August 15th will be given a dividend of 0.061 per share by the financial services provider on Tuesday, September 4th. This represents a $0.73 annualized dividend and a yield of 7.75%. The ex-dividend date is Tuesday, August 14th.

  • [By Shane Hupp]

    Hollencrest Capital Management decreased its stake in Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) by 30.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,587 shares of the financial services provider’s stock after selling 9,649 shares during the period. Hollencrest Capital Management’s holdings in Nuveen Preferred & Income Oprtnts Fnd were worth $200,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    News headlines about Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) have trended positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Nuveen Preferred & Income Oprtnts Fnd earned a media sentiment score of 0.42 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 48.1302177844966 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Hot Performing Stocks To Watch For 2019: Burcon Nutrascience Corp(BUR)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Burford Capital Limited (LON:BUR) have received a consensus recommendation of “Buy” from the six research firms that are covering the company, MarketBeat reports. Five investment analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have covered the stock in the last year is GBX 1,593.60 ($21.22).

  • [By Max Byerly]

    Burford Capital (LON:BUR)‘s stock had its “sell” rating reaffirmed by analysts at Canaccord Genuity in a note issued to investors on Wednesday. They currently have a GBX 1,543 ($20.16) target price on the stock. Canaccord Genuity’s price objective would suggest a potential downside of 17.49% from the stock’s current price.

  • [By Ethan Ryder]

    Press coverage about Burcon Nutrascience (NASDAQ:BUR) (TSE:BU) has trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Burcon Nutrascience earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned news headlines about the biotechnology company an impact score of 46.7838004109175 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Leave a Reply

Your email address will not be published. Required fields are marked *